This applies to Ozempic, Wegovy, Mounjaro and other GLP-1 receptor agonists currently approved for obesity or diabetes management
It can have a wide range of negative health effects
Here are some suggestions on how to incorporate the medicine into your daily routine: Weekly reminders on your injection schedules
Glucagon-like peptide-1 agonists (GLP-1) are a class of medications that can be extremely effective at reducing blood sugar and A1C levels for those with type 2 diabetes
Consistent macros for goal-oriented eating: Predictable calorie and protein ranges across meals, with dedicated plans for specific outcomes (weight loss, high protein, GLP-1 support, gluten-free)
They have not been evaluated by the Food and Drug Administration, and are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety